Top Markets
Coin of the day
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Rank in Stocks #32811
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Share Price
$2.22
Last synced: 2026-08-17
Market Cap
$9.03M
Change (1 day)
-3.13%
Change (1 year)
-24.26%
Country
JP
Trade PhoenixBio Co., Ltd. (6190)

Category

Stock price history for PhoenixBio Co., Ltd. (6190)
Highest end of day price: $2.26 on 2026-08-01

Lowest end of day price: $22.51 on 2016-03-01
Stock price history of PhoenixBio Co., Ltd. from 2016 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -11.29%
2025 45.96%
2024 -30.54%
2023 -37.47%
2022 10.54%
2021 -19.56%
2020 -25.90%
2019 13.30%
2018 -31.36%
2017 -30.45%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$515.58 32.24%
US
$992.01 50.00%
NL
$736.64 6.99%
CH
$1.07K -6.01%
KR
$255.50 12.02%
BE